(Q64081729)

7 January 2021

Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

The Genetics of Multiple Sclerosis: From 0 to 200 in 50 Years.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Effectiveness and cost-effectiveness of interferon beta and glatiramer acetate in the UK Multiple Sclerosis Risk Sharing Scheme at 6 years: a clinical cohort study with natural history comparator

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Incidence and prevalence of multiple sclerosis in the Americas: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Incidence and prevalence of multiple sclerosis in Europe: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

The changing demographic pattern of multiple sclerosis epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Incidence of multiple sclerosis in multiple racial and ethnic groups

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

New diagnostic criteria for multiple sclerosis: guidelines for research protocols

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

PROGNOSTIC CRITERIA IN MULTIPLE SCLEROSIS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Disability weights for the Global Burden of Disease 2013 study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

A systematic review of modifiable risk factors in the progression of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Epidemiology in multiple sclerosis: a pilgrim's progress

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Excess mortality among patients with multiple sclerosis in Denmark has dropped significantly over the past six decades: a population based study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Breastfeeding, ovulatory years, and risk of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991-2010).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

The incidence and prevalence of multiple sclerosis in Nova Scotia, Canada

2 references

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

12 December 2020

Prevalence of multiple sclerosis in Denmark 1950--2005.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Factors in the rising prevalence of multiple sclerosis in the north-east of Ireland.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Prevalence and incidence of multiple sclerosis in Panama (2000-2005)

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

MS incidence and prevalence in Africa, Asia, Australia and New Zealand: A systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

The rising prevalence and changing age distribution of multiple sclerosis in Manitoba

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Viruses and endogenous retroviruses in multiple sclerosis: From correlation to causation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Smoking and multiple sclerosis: A systematic review and meta-analysis using the Bradford Hill criteria for causation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

MS Sunshine Study: Sun Exposure But Not Vitamin D Is Associated with Multiple Sclerosis Risk in Blacks and Hispanics.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

The role of diet in multiple sclerosis: A review.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression: Towards Characterization of the "MS Microbiome".

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Excess Body Weight during Childhood and Adolescence Is Associated with the Risk of Multiple Sclerosis: A Meta-Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Mortality in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2818%2930443-5

7 January 2021

Epidemiological studies in the Upernavik district, Greenland. Incidence of some chronic diseases 1950-1974.

1 reference

12 December 2020

Prevalence of disseminated sclerosis in Northern Ireland.

1 reference

12 December 2020

PROBLEMS OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS: REPORT BY THE PANEL ON THE EVALUATION OF EXPERIMENTAL TRIALS OF THERAPY IN MULTIPLE SCLEROSIS.

1 reference

12 December 2020

Multiple sclerosis in the Faroe Islands. 8. Notifiable diseases

1 reference

12 December 2020

The prevalence of multiple sclerosis in 3 US communities

1 reference

12 December 2020

Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015

1 reference

12 December 2020